Blueprint Medicines (BPMC) shares ended the last trading session 18.2% higher at $103.36. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

In today’s global economy, industrial companies drive innovation, job creation and economic transformation. For rural ...

Gov.-elect Bob Ferguson released his blueprint Thursday for chopping billions in state spending while investing millions in education and public safety in his first term — without the aid ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Drawing from three decades of frontline experience and scholarly research, Ron Tiffen’s groundbreaking new book “Disability ...

Jensen Huang unveiled the company's most ambitious consumer tech lineup with AI computers, agents and the new GeForce RTX 5000 Series GPUs.

Gov. Laura Kelly looks back on the roster of bipartisan tax, education, child welfare, worker compensation and other policy ...